OpenAI Announces Use of Codex and ChatGPT in Antimicrobial Research

OpenAI announced today the use of its AI tools, Codex and ChatGPT, by researcher César de la Fuente and his lab to accelerate the discovery of new antimicrobial molecules. This research aims to combat drug-resistant infections, which were responsible for approximately five million deaths in 2021 and are projected to double by 2050.

César de la Fuente and his team are exploring the genomes of living and extinct organisms to identify potential antimicrobial molecules. Traditionally, this process can take years, but with the help of AI, the initial search can be reduced to hours. The lab's deep-learning models are trained to recognize patterns in biological sequences, enabling them to sift through vast genome and protein datasets efficiently.

In addition to their own AI models, the lab utilizes ChatGPT and Codex to brainstorm hypotheses, write and refine code, process datasets, analyze results, and connect ideas across scientific disciplines. This transdisciplinary approach, involving expertise from biology, chemistry, computer science, and engineering, is facilitated by AI tools that bridge the gaps between different scientific fields.

De la Fuente values AI's ability to help shape hypotheses and access the world's information quickly. He notes that AI lowers barriers to cross-disciplinary collaboration, allowing biologists to build programs and programmers to tackle biological problems. The use of AI also enables lab members to work in their native languages, further accelerating their workflows.

This research underscores the potential of AI in accelerating scientific discovery and addressing global health challenges such as antimicrobial resistance.

Source: openai